Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Return on Sales (2021 - 2025)

Historic Return on Sales for Krystal Biotech (KRYS) over the last 4 years, with Q4 2025 value amounting to 0.48%.

  • Krystal Biotech's Return on Sales fell 200.0% to 0.48% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.53%, marking a year-over-year increase of 2200.0%. This contributed to the annual value of 0.53% for FY2025, which is 2200.0% up from last year.
  • Latest data reveals that Krystal Biotech reported Return on Sales of 0.48% as of Q4 2025, which was down 200.0% from 0.81% recorded in Q3 2025.
  • Krystal Biotech's Return on Sales' 5-year high stood at 46.63% during Q4 2021, with a 5-year trough of 0.02% in Q1 2024.
  • Over the past 4 years, Krystal Biotech's median Return on Sales value was 0.44% (recorded in 2025), while the average stood at 5.84%.
  • Per our database at Business Quant, Krystal Biotech's Return on Sales tumbled by -91100bps in 2024 and then surged by 4900bps in 2025.
  • Krystal Biotech's Return on Sales (Quarter) stood at 46.63% in 2021, then tumbled by -100bps to 0.21% in 2023, then skyrocketed by 142bps to 0.5% in 2024, then fell by -4bps to 0.48% in 2025.
  • Its Return on Sales stands at 0.48% for Q4 2025, versus 0.81% for Q3 2025 and 0.4% for Q2 2025.